SAN

85.44

-0.67%↓

MRK1

119.8

+2.39%↑

ARGX

795.4

+1.87%↑

PHIA

24.08

-0.5%↓

ONC.US

337.65

+2.44%↑

SAN

85.44

-0.67%↓

MRK1

119.8

+2.39%↑

ARGX

795.4

+1.87%↑

PHIA

24.08

-0.5%↓

ONC.US

337.65

+2.44%↑

SAN

85.44

-0.67%↓

MRK1

119.8

+2.39%↑

ARGX

795.4

+1.87%↑

PHIA

24.08

-0.5%↓

ONC.US

337.65

+2.44%↑

SAN

85.44

-0.67%↓

MRK1

119.8

+2.39%↑

ARGX

795.4

+1.87%↑

PHIA

24.08

-0.5%↓

ONC.US

337.65

+2.44%↑

SAN

85.44

-0.67%↓

MRK1

119.8

+2.39%↑

ARGX

795.4

+1.87%↑

PHIA

24.08

-0.5%↓

ONC.US

337.65

+2.44%↑

Search

Vetoquinol SA

Închisă

SectorSănătate

72.3 2.26

Rezumat

Modificarea prețului

24h

Curent

Minim

69.6

Maxim

72.3

Indicatori cheie

By Trading Economics

Venit

-9.8M

25M

Vânzări

-17M

258M

P/E

Medie Sector

14.255

80.03

Randament dividend

1.21

Marjă de profit

9.734

Angajați

2,497

EBITDA

-12M

48M

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.21%

2.29%

Statistici piață

By TradingEconomics

Capitalizare de piață

-50M

860M

Deschiderea anterioară

70.04

Închiderea anterioară

72.3

Sentimentul știrilor

By Acuity

50%

50%

162 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

Vetoquinol SA Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

2 dec. 2025, 17:29 UTC

Principalele dinamici ale pieței
Achiziții, Fuziuni, Preluări

Laurentian Bank Shares Hit Two-Year High on Plans for Break-Up, Takeover

2 dec. 2025, 16:21 UTC

Câștiguri

Scotiabank Aiming for Earnings Growth After Capital Markets Buoy Results in Latest Quarter -- Update

2 dec. 2025, 16:18 UTC

Câștiguri

Correction to Scotiabank Quarterly Earnings Buoyed Article

2 dec. 2025, 23:53 UTC

Market Talk

Nikkei May Rise After Gains on Wall Street -- Market Talk

2 dec. 2025, 22:48 UTC

Câștiguri

Marvell's Stock Soars On Data Center Forecast -- Barrons.com

2 dec. 2025, 22:12 UTC

Market Talk

Australian 3Q GDP To Show Modest Recovery In Play -- Market Talk

2 dec. 2025, 22:03 UTC

Market Talk

Minerals 260's Resource Upgrade Looks Impressive -- Market Talk

2 dec. 2025, 22:00 UTC

Market Talk

Global Equities Roundup: Market Talk

2 dec. 2025, 22:00 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

2 dec. 2025, 22:00 UTC

Market Talk

Fletcher Building Loses Bull Due to Tame Housing-Market Recovery -- Market Talk

2 dec. 2025, 21:56 UTC

Câștiguri

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2 dec. 2025, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

2 dec. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2 dec. 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

2 dec. 2025, 21:44 UTC

Câștiguri

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2 dec. 2025, 21:38 UTC

Market Talk

Sky Network TV Has Path to Grow Dividend by 33% -- Market Talk

2 dec. 2025, 21:19 UTC

Câștiguri

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2 dec. 2025, 20:06 UTC

Market Talk

Oil Futures Fall Amid Russia-Ukraine Peace Talks -- Market Talk

2 dec. 2025, 19:55 UTC

Market Talk

Natural Gas Futures Fall Amid Uncertain Weather Forecasts -- Market Talk

2 dec. 2025, 19:53 UTC

Market Talk
Câștiguri

Global Equities Roundup: Market Talk

2 dec. 2025, 19:53 UTC

Market Talk
Câștiguri

Scotiabank ROE Target Viewed as Possibly Conservative -- Market Talk

2 dec. 2025, 19:24 UTC

Market Talk

Analysts Project Uptick in U.S. Ethanol Stocks -- Market Talk

2 dec. 2025, 19:06 UTC

Market Talk

Precious Metals Step Back After Silver Sets Record -- Market Talk

2 dec. 2025, 18:27 UTC

Achiziții, Fuziuni, Preluări

Kraken to Acquire Backed Finance AG

2 dec. 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

2 dec. 2025, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

2 dec. 2025, 15:17 UTC

Market Talk

Natural Gas Extends Gains Amid Cold Weather -- Market Talk

2 dec. 2025, 14:47 UTC

Market Talk

BOE Likely to Cut Rates Further, Weakening Sterling -- Market Talk

2 dec. 2025, 14:38 UTC

Market Talk

Silver Steps Back From Record Levels -- Market Talk

2 dec. 2025, 14:31 UTC

Market Talk
Câștiguri

Scotiabank Strong Quarter Driven By Capital Markets Growth -- Market Talk

Comparație

Modificare preț

Vetoquinol SA Așteptări

Consens privind evaluarea

By TipRanks

0 ratings

0

Cumpărare

0

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

72.6 / 75.1Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

162 / 374 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
help-icon Live chat